[Federal Register Volume 84, Number 154 (Friday, August 9, 2019)]
[Notices]
[Pages 39383-39384]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-17060]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2019-0154]


Release of Patients Administered Radioactive Material

AGENCY: Nuclear Regulatory Commission.

ACTION: Draft regulatory guide; extension of comment period.

-----------------------------------------------------------------------

SUMMARY: On July 29, 2019, the U.S. Nuclear Regulatory Commission (NRC) 
requested comments on draft regulatory guide (DG), DG-8057, ``Release 
of Patients Administered Radioactive Material.'' The public comment 
period was originally scheduled to close on August 26, 2019. The NRC is 
extending the public comment period to allow more time for members of 
the public to submit their comments.

DATES: The due date of comments requested in the document published on 
July 29, 2019 (84 FR 36127) is extended. Comments should be filed no 
later than September 26, 2019. Comments received after this date will 
be considered, if it is practical to do so, but the Commission is able 
to ensure consideration only for comments received on or before this 
date.

ADDRESSES: You may submit comments by any of the following methods:
     Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC-2019-0154. Address 
questions about NRC dockets IDs in Regulations.gov to Jennifer Borges; 
telephone: 301-287-9127; email: [email protected]. For technical 
questions, contact the individual listed in the FOR FURTHER INFORMATION 
CONTACT section of this document.
     Mail comments to: Office of Administration, Mail Stop: 
TWFN-7-A60M, U.S. Nuclear Regulatory Commission, Washington, DC 20555-
0001, ATTN: Program Management, Announcements and Editing Staff.
    For additional direction on obtaining information and submitting 
comments, see ``Obtaining Information and Submitting Comments'' in the 
SUPPLEMENTARY INFORMATION section of this document.

FOR FURTHER INFORMATION CONTACT: Vered Shaffer, Office of Nuclear 
Regulatory Research, U.S. Nuclear Regulatory Commission, Washington, DC 
20555-0001; telephone: 630-829-9862, email: [email protected].

SUPPLEMENTARY INFORMATION: 

I. Obtaining Information and Submitting Comments

A. Obtaining Information

    Please refer to Docket ID NRC-2019-0154 when contacting the NRC 
about the availability of information for this action. You may obtain 
publicly-available information related to this action by any of the 
following methods:
     Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC-2019-0154
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly-available documents online in the 
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``Begin Web-based ADAMS 
Search.'' For problems with ADAMS, please contact the NRC's Public 
Document Room (PDR) reference staff at 1-800-397-4209, 301-415-4737, or 
by email to [email protected]. The DG-8057 is available in ADAMS 
under Accession No. ML19108A463.
     NRC's PDR: You may examine and purchase copies of public 
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 
Rockville Pike, Rockville, Maryland 20852.

B. Submitting Comments

    Please include Docket ID NRC-2019-0154, in your comment submission. 
The NRC cautions you not to include identifying or contact information 
that you do not want to be publicly disclosed in your comment 
submission. The NRC will post all comment submissions at https://www.regulations.gov as well as enter the comment submissions into 
ADAMS. The NRC does not routinely edit comment submissions to remove 
identifying or contact information.
    If you are requesting or aggregating comments from other persons 
for submission to the NRC, then you should inform those persons not to 
include identifying or contact information that they do not want to be 
publicly disclosed in their comment submission. Your request should 
state that the NRC does not routinely edit comment submissions to 
remove such information before making the comment submissions available 
to the public or entering the comment into ADAMS.

II. Discussion

    On July 29, 2019, the NRC published a document in the Federal 
Register (84 FR 36127) requesting comments on DG-8057, ``Release of 
Patients Administered Radioactive Material.'' This draft guide, 
Revision 1, provides licensees with more detailed instructions to 
provide to patients before and after they have been administered 
radioactive material than was in Revision 0. In addition, the guide 
includes a new section on ``Death of a Patient Following 
Radiopharmaceutical or Implants Administrations,'' as well as 
requirements for recordkeeping. Also, Table 3, ``Dosages of 
Radiopharmaceuticals that Require Instructions and Records When 
Administered to Patients who are Breastfeeding an Infant or Child,'' 
has been revised to provide information for the recommended duration of 
interruption of breastfeeding to ensure that the dose to an infant or 
child meets the NRC's regulatory requirements. The public comment 
period was originally scheduled to close on August 26, 2019. The NRC 
staff has decided to extend the public comment period on this document 
until September 26, 2019, to allow more time for members of the public 
to submit their comments.

    Dated at Rockville, Maryland, this 6th day of August, 2019.


[[Page 39384]]


    For the Nuclear Regulatory Commission.
Thomas H. Boyce,
Chief, Regulatory Guidance and Generic Issues Branch, Division of 
Engineering, Office of Nuclear Regulatory Research.
[FR Doc. 2019-17060 Filed 8-8-19; 8:45 am]
 BILLING CODE 7590-01-P